Avalo Therapeutics, Inc.AVTXNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank100
3Y CAGR+35.1%
5Y CAGR+106.2%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+35.1%/yr
vs +116.8%/yr prior
5Y CAGR
+106.2%/yr
Recent deceleration
Acceleration
-81.7pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
37.3x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $134.55M | +1714.5% |
| 2023 | $7.42M | -43.7% |
| 2022 | $13.17M | -75.9% |
| 2021 | $54.59M | +188.5% |
| 2020 | $18.92M | +424.2% |
| 2019 | $3.61M | -66.1% |
| 2018 | $10.65M | +330.6% |
| 2017 | $2.47M | -51.8% |
| 2016 | $5.13M | -75.8% |
| 2015 | $21.16M | - |